Statement of Changes in Beneficial Ownership (4)
October 31 2018 - 04:05PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Radov A. Jeffrey
|
2. Issuer Name
and
Ticker or Trading Symbol
BioRestorative Therapies, Inc.
[
BRTX
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
_____ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Last)
(First)
(Middle)
8 WALWORTH AVENUE
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
10/29/2018
|
(Street)
SCARSDALE, NY 10583
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
|
|
|
|
|
|
|
12500
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Stock Option
|
$4.7
|
|
|
|
|
|
|
(1)
|
2/9/2022
|
Common Stock
|
30000
|
|
30000
|
D
|
|
Stock Option
|
$4.7
|
|
|
|
|
|
|
(2)
|
12/7/2022
|
Common Stock
|
5000
|
|
5000
|
D
|
|
Stock Option
|
$4.7
|
|
|
|
|
|
|
(3)
|
10/4/2023
|
Common Stock
|
12500
|
|
12500
|
D
|
|
Stock Option
|
$4.7
|
|
|
|
|
|
|
(4)
|
2/18/2024
|
Common Stock
|
25000
|
|
25000
|
D
|
|
Stock Option
|
$4.7
|
|
|
|
|
|
|
(5)
|
10/23/2024
|
Common Stock
|
50000
|
|
50000
|
D
|
|
Stock Option
|
$4.7
|
|
|
|
|
|
|
(6)
|
9/4/2025
|
Common Stock
|
115500
|
|
115500
|
D
|
|
Stock Option
|
$3.73
|
|
|
|
|
|
|
(7)
|
6/10/2026
|
Common Stock
|
128000
|
|
128000
|
D
|
|
Stock Option
|
$3.35
|
|
|
|
|
|
|
(8)
|
6/23/2027
|
Common Stock
|
125000
|
|
125000
|
D
|
|
Stock Option
|
$1.23
|
10/29/2018
|
|
A
|
|
75000
|
|
(9)
|
10/29/2028
|
Common Stock
|
75000
|
$0
|
75000
|
D
|
|
Explanation of Responses:
|
(1)
|
The option is exercisable to the extent of 15,000 shares on each of February 10, 2012 and February 10, 2013.
|
(2)
|
The option is exercisable to the extent of 2,500 shares on each of December 7, 2012 and December 7, 2013.
|
(3)
|
The option is exercisable to the extent of 6,250 shares on each of October 4, 2013 and October 4, 2014.
|
(4)
|
The option is exercisable to the extent of 8,334 shares on February 18, 2014, and 8,333 shares on each of February 18, 2015 and February 18, 2016.
|
(5)
|
The option is exercisable to the extent of 16,667 shares on each of October 23, 2015 and Octobe 23, 2016 and 16,666 shares on October 23, 2017.
|
(6)
|
The option is exercisable to the extent of 57,750 shares on December 22, 2015, and 19,250 shares on each of September 4, 2016, September 4, 2017 and September 4, 2018.
|
(7)
|
The option is exercisable to the extent of 42,667 shares on each of June 10, 2016 and June 10, 2017, and 42,666 shares on June 10, 2018.
|
(8)
|
The option is exercisable to the extent of 41,667 shares on each of June 23, 2017 and June 23, 2018, and 41,666 shares on June 23, 2019.
|
(9)
|
The option is exercisable to the extent of 25,000 shares on each of October 29, 2018, October 29, 2019 and October 29, 2020.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Radov A. Jeffrey
8 WALWORTH AVENUE
SCARSDALE, NY 10583
|
X
|
|
|
|
Signatures
|
/s/ A. Jeffrey Radov
|
|
10/30/2018
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|